Danaher Corporation (DHR)☆

Danaher is a life-sciences and diagnostics conglomerate. It is a member of the S&P 500 and is classified in the Health Care sector — pharmaceutical, biotech, device and managed-care companies.

Danaher Corporation trades on the NYSE under the ticker symbol DHR. As of the most recent market data, the stock was priced around $203.83, down 0.58% on the session, giving Danaher Corporation a market capitalization of roughly $144.26B.

Over the past 52 weeks, DHR has traded between $160.93 and $242.80. Shares are valued at a trailing price-to-earnings (P/E) ratio of about 39.7, a common gauge of how richly the market prices the company's earnings. Danaher Corporation also pays a dividend, currently yielding around 78.00%.

As one of the larger companies in the Health Care sector, Danaher Corporation is closely followed by investors and often moves with broader trends across pharmaceutical, biotech, device and managed-care companies. Traders watch DHR for earnings reports, analyst rating changes, and headlines that can shift sentiment — each of which is summarized on this page as it breaks.

Because the S&P 500 is weighted by market value, Danaher Corporation's size means its share-price moves can also nudge the index as a whole, making DHR a stock that even index investors pay attention to.